SC 13D/A

GKCC, LLC ELICIO THERAPEUTICS, INC. SCHEDULE 13D/A

Company: Elicio Therapeutics, Inc.
Filed: August 14, 2024
Accession Number: 0001068238-24-000167

View Document ↗ View on SEC.gov ↗